Fernando Mateus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vise Technologies Inc. acquired a new stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) during the 1st quarter, HoldingsChannel.com reports. The firm acquired 2,143 shares of the healthcare product maker’s stock, valued at approximately $254,000. Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Vanguard Group […]

Fairview Capital Investment Management LLC trimmed its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 2.9% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,065 shares of the healthcare product maker’s stock after selling 150 shares during the quarter. Fairview Capital Investment […]